Lv2
195 积分 2021-05-11 加入
Three-year follow-up analysis of first-line axicabtagene ciloleucel for high-risk large B-cell lymphoma: the ZUMA-12 study
5天前
已完结
Three-year follow-up analysis of first-line axicabtagene ciloleucel for high-risk large B-cell lymphoma: the ZUMA-12 study
7天前
已完结
Chavez JC, Dickinson M, Munoz J, et al. Three-year follow-up analysis of first-line axicabtagene ciloleucel for high-risk large B-cell lymphoma: the ZUMA-12 study. Blood. 2025;145(20):2303-2311
7天前
已完结
Paraventricular nucleus–locus coeruleus VGlut2 neural circuit regulates energy metabolism in mice
11天前
已完结
Demystifying the diagnosis and management of ICUS, CHIP, and CCUS
12天前
已关闭
Outcomes in patients with relapsed/refractory multiple myeloma with extramedullary disease: a meta-analysis
17天前
已完结
The impact of extramedullary and paraskeletal plasmacytomas on treatment outcomes in multiple myeloma treated with teclistamab: U.S. Myeloma Immunotherapy Consortium real-world experience
21天前
已完结
A comparison of mobilization regimens used in Hodgkin lymphoma and factors that influence peripheral blood stem cell mobilization
1个月前
已完结
Discovery of Dysimmunity in Large Granular Lymphocytic Leukemia (LGLL) using Bioinformatic Analysis
2个月前
已完结
Identification of Key Genes and Pathways Associated with Hepatosplenic T-Cell Lymphoma (HSTCL) by Bioinformatics Analysis
2个月前
已完结
皖公网安备34019202002308
